By Ned Stafford FRANKFURT, Germany (Reuters Health) – An expert committee that advises the German government on prescription drugs has recommended that the herbal medicine
NEW YORK (Reuters Health) – In a head-to-head comparison, nasal steroid therapy won out over short-course specific immunotherapy in reducing symptoms of seasonal rhinoconjunctivitis, Scandinavian
By Melissa Schorr NEW YORK (Reuters Health) – New survey results suggest that 1 in 10 general practice physicians might prescribe an antibiotic to penicillin-sensitive
NEW YORK (Reuters Health) – Results of a small randomized trial show that the preventive use of the antiepileptic drug, topiramate, significantly reduces the frequency
לכתבה ב "הארץ"
By Will Boggs, MD NEW YORK (Reuters Health) – The presence of cyclooxygenase 2 (COX-2)-positive T cells in the small intestinal mucosa of patients with
By Robert Parsons GENEVA (Reuters Health) – The World Health Organisation's Executive Board on Friday passed a resolution urging member states to improve access to
הודעה ראשונה על רשימת התרופות והטכנולוגיות שיתווספו לסל הבריאות בשנת 2002 , דיווח מעתון הארץ למאמר בהארץ
By William Langbein NEW YORK (Reuters Health) – A two-year, online survey from a healthcare research group indicates seniors may be gradually accepting higher payments
By Peter Ramjug GAITHERSBURG, MD (Reuters) – A US advisory panel on Thursday backed GlaxoSmithKline Plc's Flovent and Advair to treat chronic obstructive pulmonary disease
By Peter O'Donnell BRUSSELS (Reuters Health) – The European Union has taken a new step towards catching herbal medicines in its net of rules on
By Alicia Ault SILVER SPRING, MD (Reuters Health) – A US Food and Drug Administration (FDA) advisory committee voted 7-1, with one abstention, against approval
NEW YORK (Reuters Health) – Women and older patients experience greater antihypertensive effects from treatment with the controlled-onset, extended-release (COER) formulation of the calcium antagonist
By Richard Woodman LONDON (Reuters Health) – Fifty-seven people have died and nearly 7000 have reported suspected adverse reactions in Britain after taking GlaxoSmithKline's smoking
WASHINGTON (Reuters Health) – Switzerland's Roche Holding AG issued a statement Wednesday clarifying that the company's recently disclosed production problems would only affect the pediatric
LONDON (Reuters Health) – Offering reassurance and education to patients about the uncertain benefit of antibiotics in cases of acute bronchitis can reduce the rate
By William Langbein SAN FRANCISCO (Reuters Health) – An unlikely coalition between major corporations and large national unions may offer hope to correct the problem
By Peter O'Donnell BRUSSELS (Reuters Health) – European plans to let drug companies give consumers more information on prescription drugs faced turbulent times on Thursday
NEW YORK (Reuters Health) – Aspirin is protective for most types of patients at risk for occlusive vascular events, according to the Antithrombotic Trialists' Collaboration